Gregory M. Fahy, Ph.D. is a cryobiologist and biogerontologist and the Chief Scientific Advisor to Longevity Bridge.
Dr. Fahy is the originator and Editor-in-Chief of The Future of Aging: Pathways to Human Life Extension. He recently conducted a Stanford University based human clinical trial focused on the reversal of human immune system aging.
Fahy is the world’s foremost expert in organ cryopreservation by vitrification and is the Vice President and Chief Scientific Officer at Twenty-First Century Medicine, Inc.
Dr. Fahy is a member of the Board of Governors of the Society for Cryobiology and served for 16 years as a Director of the American Aging Association.
Aubrey de Grey, Ph.D. is a biomedical gerontologist, mathematician and author.
He is the Chief Science Officer of the SENS Research Foundation, VP of New Technology Discovery at AgeX Therapeutics, Inc., and Editor-in-Chief of Rejuvenation Research.
Dr. de Grey’s research focuses on whether regenerative medicine can prevent the aging process through SENS (Strategies for Engineered Negligible Senescence), a collection of proposed regenerative medicine techniques to rejuvenate the human body and stop aging.
Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association.
Alexandra Stolzig, PhD. is Professor for Biogerontological Bioengineering at Loughborough University.
In the past, she served as the Head of Stem Cell Biology Group at the Fraunhofer Institute for Cell Therapy and Immunology and as Vice President for Research at BioAge Labs. She completed her PhD degree at the Humboldt University of Berlin.
With over twenty years in aging and regenerative medicine research, some of Alexandra’s achievements include developing a new way of creating iPS cells for clinical use to help develop therapies for aging as well as developing stem cell treatments for Alzheimer’s disease. Alexandra has published over 65 peer-reviewed research papers.
Michael Rae is the author of five scientific articles and commentaries in peer-reviewed scientific journals.
Much of Mr. Rae’s work has been devoted to elucidating the Strategies for Engineered Negligible Senescence platform for anti-aging biomedicine for a popular audience. His undergraduate minor was in biology. He is a long-time member and one-time Board Member of the Calorie Restriction Society, a main contributor to the Society’s “How-to Guide”, and was core scientific investigator with the CR Society Cohort Study.
Michael Kope is the President, Chief Executive Officer, and Co-founder of the SENS Research Foundation.
Mr. Kope received his J.D. from the University of Michigan in 1990. He has served as the University of Michigan’s Intellectual Property Counsel; as Director of Corporate Development for Aviron, and for MedImmune, Inc.; and as CEO and officer of a number of start-ups in the biotechnology space. He specializes in business development and consulting, and is widely experienced with biotechnology organizations. Mike has negotiated a broad range of business acquisition and partnership agreements, designed strategies for technology protection and promotion in many fields of research, and facilitated a number of successful startups.
Brian Dean Abramson, Esq., LL.M. is an intellectual property attorney and the world’s foremost expert on the law governing vaccination and immunization.
Mr. Abramson is the author of the leading legal treatise on the topic, Vaccine, Vaccination, and Immunization Law, published by Bloomberg Law in cooperation with the American Health Lawyers Association. In addition to discussing the litany of regulations and legal regimes affecting vaccination, the treatise covers prospective vaccines for conditions including cancer and Alzheimer’s disease.
Abramson has previously been an editor for legal news provider Bloomberg BNA, a law clerk for Judge Pauline Newman of the United States Court of Appeals for the Federal Circuit, in Washington, D.C., and an intellectual property attorney with the firm of Lott & Fischer, in Coral Gables, Florida. He received his Juris Doctor, summa cum laude, from the Florida International University College of Law, and his Master of Laws in Intellectual Property Law, with highest honors, from The George Washington University Law School.